Dapagliflozin Has No Significant Effect on Cardiac Remodeling in T2D
Researchers sought to determine whether dapagliflozin could help reverse left ventricular remodeling in patients with type 2 diabetes.
AHA 2021 Heart Failure In-depth
Tolvaptan Useful in Short-Term Dyspnea Relief During HF Hospitalization
Researchers analyzed the effects of using tolvaptan as add-on therapy for patients hospitalized with acute heart failure.
Early Drop in Systolic BP Associated With All-Cause Mortality in Acute HF
Through a subanalysis of the REALITY-AHF study, researchers were able to assess the negative effects of an early drop in systolic blood pressure in patients with acute heart failure.
Discharge on Sacubitril/Valsartan Shows Survival Benefit in HFrEF
ARNI vs ACE inhibitors or ARB and outcomes in patients with HFrEF.
MRA Cessation Increases Mortality Risk in HF Patients With Hyperkalemia
Study investigators analyzed the effects of MRA cessation on risk-benefit balance of patients with heart failure and hyperkalemia.
GLP-1 Receptor Agonists Linked to Lower Insulin Doses, HbA1c, Hospitalization in HF
Researchers examined the outcomes of GLP-1 receptor agonist therapy in patients with heart failure.
- Loading...
Loading...
Next post in AHA 2021 Heart Failure In-depth
Loading... 
Loading...